Emrock Corporation Converts 55 Lakh Warrants Into Equity Shares

Emrock Corporation Limited approved the conversion of 55 lakh warrants into 55 lakh equity shares on October 30, 2026, receiving Rs 4.5375 crore at Rs 8.25 per warrant. The conversion raised the company’s reported paid-up capital to Rs 21.32 crore and left 74.35 lakh warrants pending conversion.

What did Emrock Corporation approve on October 30, 2026?

Emrock Corporation approved the allotment of 55 lakh equity shares following the conversion of an equal number of warrants. The company received Rs 4.5375 crore, which is equal to Rs 8.25 for each of the 55 lakh warrants converted.

The transaction increased the company’s reported paid-up share capital to Rs 21.32 crore. The information provided also refers to total share capital across 2.132 million shares. However, this share-count presentation should be read with caution because it is not numerically aligned with the 55 lakh shares converted or with the company’s earlier reported outstanding share capital of 1.582 crore shares.

After the latest allotment, 74.35 lakh warrants remain pending conversion. These outstanding instruments represent the unconverted portion of Emrock Corporation’s larger preferential warrant programme and remain relevant to the company’s future equity structure.

How does the conversion fit Emrock Corporation’s warrant programme?

The conversion forms part of a preferential warrant programme approved in May 2025. Emrock Corporation had allotted 2,35,35,491 convertible warrants to promoters and non-promoters after shareholder approval, in-principle approval from BSE Ltd, and compliance with the Companies Act, 2013 and SEBI ICDR Regulations, 2018.

The supplied disclosures state that the warrants were allotted at Rs 11 each in May 2025. Separately, the October 2026 update records a receipt of Rs 8.25 per warrant for the latest conversion. The disclosures do not provide a detailed reconciliation between the original warrant issue price and the amount received on this conversion.

By December 2025, the company had converted 1.06 crore warrants, lifting paid-up capital from Rs 5.22 crore to Rs 15.82 crore, while 1.29 crore warrants remained outstanding. The October 2026 conversion and the reported balance of 74.35 lakh pending warrants show that the programme has continued to alter Emrock Corporation’s equity base over time.

The warrant programme is important because conversion creates new equity shares and brings cash into the company. At the same time, every conversion changes the number of outstanding shares, which is a material consideration for existing shareholders assessing ownership and capital structure.

Why has Emrock Corporation’s ownership structure changed?

Emrock Corporation’s ownership structure changed after a Gujarat-based promoter group acquired control in early 2025. Jatinkumar Tulsibhai Patel, Parth Tulsibhai Patel and Arjunkumar Jagdishbhai Patel acquired 67.24% from the founding Savla family at about Rs 7.50 per share, followed by a mandatory open offer at Rs 11 per share.

The Savla directors resigned on January 7, 2025, after which the Patel group took board and management control. The company’s annual report said the completion of the open offer led to a significant change in the shareholding structure, promoters and board composition.

Promoter ownership was reported at 74.63% as of October 2026, while retail ownership was reported at about 25.37%. Mutual funds, insurance companies, foreign institutional investors and domestic institutional investors were each shown with 0.00% ownership in the supplied shareholding summary.

The high promoter holding means warrant conversion must be assessed alongside the identity of warrant holders and the final ownership outcome. The information supplied states that the promoter group received roughly 1.74 crore of the original warrant allotment, but it does not specify the holder-wise allocation for the October 2026 conversion.

What businesses is Emrock Corporation adding after the promoter change?

Emrock Corporation has expanded its stated business interests into renewable energy, energy, pharmaceuticals, construction and hospitality after the change in control. The company’s purpose clause was revised within months of the new promoter group taking charge to include these additional areas.

In renewable energy, Emrock Corporation acquired a 51% stake in Emrock Renewable Private Limited through a cash subscription of Rs 51,000 for 5,100 equity shares of face value Rs 10 each. The subsidiary is intended to engage in solar photovoltaic manufacturing, energy storage and renewable energy projects.

The annual report also states that the company acquired a 50.49% stake in Emrock Energy Private Limited, described as a vehicle for solar and Bio-CNG projects. The supplied material contains both the 51% Emrock Renewable investment and the 50.49% Emrock Energy investment, indicating separate entities and stated areas of activity.

In pharmaceuticals, Emrock Corporation contributed Rs 50,500 in cash for a 50.50% stake in Emrock Lifescience LLP. The company also holds a 39% stake in EMROCK SIGNATURE HOSPITALITY LLP, which was incorporated in November 2025. These investments are small in stated initial consideration but broaden the range of sectors linked to the listed company.

What does the warrant conversion mean for investors and operations?

The conversion provides Emrock Corporation with Rs 4.5375 crore of disclosed cash proceeds and increases its equity capital. For investors, the immediate effect is a larger share base following the allotment of 55 lakh new shares, alongside the possibility of further changes if the remaining 74.35 lakh warrants are converted.

No share-price movement, earnings effect, project revenue or deployment plan for the latest proceeds was provided in the supplied information. Therefore, the available disclosures establish the capital-raising and ownership implications of the conversion but do not quantify its impact on profitability or operating performance.

The company’s annual report said it moved from a loss-making position in the previous financial year to a net profit in the current period following the open offer and management transition. However, no net-profit amount was included in the material provided, so the scale of that improvement cannot be measured from these disclosures.

For industry participants, the company’s expansion into renewable energy, Bio-CNG, pharmaceuticals and hospitality places its operations across several distinct sectors. The disclosed investments and partnership vehicles show the legal structure being built for those activities, while the supplied material does not provide project timelines, operating capacity or commercial contracts.

Conclusion

Emrock Corporation’s October 30 conversion of 55 lakh warrants added Rs 4.5375 crore of disclosed funds and increased reported paid-up capital to Rs 21.32 crore. It is another step in the warrant-led recapitalisation that has followed the 2025 promoter change, while also increasing the company’s outstanding equity shares.

The next disclosed capital-structure item to watch is the treatment of the 74.35 lakh warrants still pending conversion. Investors may also monitor future disclosures on the renewable energy, energy, pharmaceutical and hospitality ventures, particularly any information on project execution, funding use or operating performance.